Chemical Structure : MBP-11901
货号: PC-47032Not For Human Use, Lab Use Only.
MBP-11901 is an orally active, multitarget tyrosine kinase inhibitor targeting FLT3, VEGFR2, PDGFRβ, and c-KIT, shows excellent inhibitory activity against HCC cell growth in vitro (HepG2, IC50=5.16 uM).
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MBP-11901 is an orally active, multitarget tyrosine kinase inhibitor targeting FLT3, VEGFR2, PDGFRβ, and c-KIT, shows excellent inhibitory activity against HCC cell growth in vitro (HepG2, IC50=5.16 uM).
MBP-11901 induces apoptosis and inhibits cell migration and invasion of HepG2 cells.
MBP-11901 binds selectively and tightly to FLT3, MAP4K2, KIT, VEGFR2, and PDGFRβ with Kd values of 295, 1100, 3850, 3550, and 4000 nM, respectively.
MBP-11901 was effective against various human HCC cell lines, leading to the disappearance of most tumors when administered orally in animal models.
分子量 | 312.391 | |
分子式 | C16H16N4OS | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Park HJ, et al. Cancers (Basel). 2022 Apr 14;14(8):1994.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright